ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive Biotech

      iShares Genomics Immunology and Healthcare ETF

      The iShares Genomics Immunology and Healthcare ETF (the ¡°Fund¡±) seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.

      $22.57

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Genomics Immunology and Healthcare ETF IDNA
      Fund Size
      $137M
      Dividend
      1.2%
      Fees
      0.47%
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $57.4B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.14 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.792
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 21.21
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -22.57
      Profitable Companies 50
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 78.78
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 9.18
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.09
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT -11.15
      Enterprise Value to Revenue Enterprise value divided by revenue 93.74
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.14
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 714.28%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 13.82%
      Return on Assets Indicates a company's profitability in relation to its total assets. -2.79%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -2.93%

      Industries

      Healthcare 79.6%
      Other 5.6%
      N/A 14.8%

      Market cap

      Micro Cap 1%
      Small Cap 22%
      Mid Cap 14%
      Large Cap 47%
      Mega Cap 15%

      54 Investments

      P/E-Ratio
      Total Investment
      Weight
      BlackRock Funds III logo

      BlackRock Funds III

      P/E-Ratio
      n/a
      Total Investment
      $12.4M
      Weight
      11.1%
      BeiGene Ltd logo

      BGNE - Manufacturing

      BeiGene Ltd

      P/E-Ratio
      -14.4
      Total Investment
      $6.73M
      Weight
      6.0%
      GSK PLC logo

      GSK - Manufacturing

      GSK PLC

      P/E-Ratio
      17.2
      Total Investment
      $6.13M
      Weight
      5.5%
      Sanofi SA logo

      SNY - Health Technology

      Sanofi SA

      P/E-Ratio
      11.3
      Total Investment
      $5.96M
      Weight
      5.3%
      Roche Holding AG logo

      RHHVF - Health Technology

      Roche Holding AG

      P/E-Ratio
      25.0
      Total Investment
      $5.92M
      Weight
      5.3%
      Exelixis Inc logo

      EXEL - Professional, Scientific, and Technical Services

      Exelixis Inc

      P/E-Ratio
      16.9
      Total Investment
      $5.8M
      Weight
      5.2%
      AstraZeneca PLC logo

      AZN - Health Technology

      AstraZeneca PLC

      P/E-Ratio
      29.2
      Total Investment
      $5.6M
      Weight
      5.0%
      Takeda Pharmaceutical Co Ltd logo

      TAK - Manufacturing

      Takeda Pharmaceutical Co Ltd

      P/E-Ratio
      50.5
      Total Investment
      $5.49M
      Weight
      4.9%
      SpringWorks Therapeutics Inc logo

      SWTX - Manufacturing

      SpringWorks Therapeutics Inc

      P/E-Ratio
      -13.9
      Total Investment
      $5.38M
      Weight
      4.8%
      Genmab A/S logo

      GMAB - Professional, Scientific, and Technical Services

      Genmab A/S

      P/E-Ratio
      17.4
      Total Investment
      $5.13M
      Weight
      4.6%
      BioNTech SE logo

      BNTX - Manufacturing

      BioNTech SE

      P/E-Ratio
      -59.1
      Total Investment
      $4.54M
      Weight
      4.1%
      Revolution Medicines Inc logo

      RVMD - Manufacturing

      Revolution Medicines Inc

      P/E-Ratio
      -8.8
      Total Investment
      $4.46M
      Weight
      4.0%
      Merck & Co Inc logo

      MRK - Manufacturing

      Merck & Co Inc

      P/E-Ratio
      12.9
      Total Investment
      $4.39M
      Weight
      3.9%
      Incyte Corp logo

      INCY - Professional, Scientific, and Technical Services

      Incyte Corp

      P/E-Ratio
      18.8
      Total Investment
      $4.38M
      Weight
      3.9%
      Regeneron Pharmaceuticals Inc logo

      REGN - Manufacturing

      Regeneron Pharmaceuticals Inc

      P/E-Ratio
      13.7
      Total Investment
      $4.08M
      Weight
      3.7%
      Arcellx Inc logo

      ACLX

      Arcellx Inc

      P/E-Ratio
      -77.7
      Total Investment
      $4.08M
      Weight
      3.6%
      Twist Bioscience Corp logo

      TWST - Professional, Scientific, and Technical Services

      Twist Bioscience Corp

      P/E-Ratio
      -19.0
      Total Investment
      $3.81M
      Weight
      3.4%
      Moderna Inc logo

      MRNA - Manufacturing

      Moderna Inc

      P/E-Ratio
      -3.2
      Total Investment
      $3.41M
      Weight
      3.1%
      BioCryst Pharmaceuticals Inc logo

      BCRX - Manufacturing

      BioCryst Pharmaceuticals Inc

      P/E-Ratio
      -48.7
      Total Investment
      $2.95M
      Weight
      2.6%
      Janux Therapeutics Inc logo

      JANX - Professional, Scientific, and Technical Services

      Janux Therapeutics Inc

      P/E-Ratio
      -13.3
      Total Investment
      $2.71M
      Weight
      2.4%
      Novavax Inc logo

      NVAX - Manufacturing

      Novavax Inc

      P/E-Ratio
      2.9
      Total Investment
      $1.8M
      Weight
      1.6%
      Iovance Biotherapeutics Inc logo

      IOVA - Manufacturing

      Iovance Biotherapeutics Inc

      P/E-Ratio
      -1.9
      Total Investment
      $1.56M
      Weight
      1.4%
      Geron Corp logo

      GERN - Manufacturing

      Geron Corp

      P/E-Ratio
      -10.6
      Total Investment
      $1.4M
      Weight
      1.3%
      Xencor Inc logo

      XNCR - Manufacturing

      Xencor Inc

      P/E-Ratio
      -3.4
      Total Investment
      $1.28M
      Weight
      1.1%
      SK Bioscience Co Ltd logo

      SK Bioscience Co Ltd

      P/E-Ratio
      n/a
      Total Investment
      $1.26M
      Weight
      1.1%
      HoMEÔçÒÒŮѸÀ×